Pharmaceutical companies Galen and Barr this morning announced that they have closed two out of the three parts of their outstanding deal originally announced last September, which was under FTC review.

Buyers enticed by Wall Street’s depressed prices moved back into the market today, giving stocks a moderate boost after a slide lasting more than two weeks.